Navigation Links
Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
Date:1/10/2011

FLORHAM PARK, N.J., Jan. 10, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.  KAPVAY™ is the first and only FDA-approved ADHD treatment indicated for use as add-on therapy to stimulant medication, in addition to use as monotherapy.

"Shionogi is extremely proud to bring KAPVAY™ to market in the U.S.," said Donald C. Manning, MD, PhD, Chief Medical Officer of Shionogi Inc.  "The extended-release version of clonidine hydrochloride found in KAPVAY™ offers an exciting new treatment option for children and adolescents with ADHD who are not experiencing adequate symptom relief from stimulants alone."  

ADHD affects more than 4.5 million children in the U.S., with at least 7 percent of U.S. school-aged children believed to suffer from the condition.  Symptoms include difficulty in maintaining attention and focus and in controlling behavior, as well as hyperactivity/over-activity.  While stimulant medications remain a first line treatment for ADHD, up to 30 percent of ADHD patients do not achieve an optimal response to stimulant monotherapy.

KAPVAY™'s recent FDA approval was based on two Phase III studies, which demonstrated significant efficacy at Week 5 in children and adolescents (6-17 years) with ADHD treated with KAPVAY™.  Signs and symptoms of ADHD were evaluated using the investigator administered and scored ADHD Rating Scale-IV-Parent Version (ADHDRS-IV) total score, including hyperactive/impulsivity and inattentive subscales.  Treatment-emergent adverse events, such as somnolence and fatigue, were mostly mild to moderate. Thirteen percent (13%) of patients
'/>"/>

SOURCE Shionogi Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
2. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
3. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
4. Shionogi Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals To Market Ospemifene
5. Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
6. Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)...   BioCision , a leader in advanced ... many areas of medical and scientific research, announced ... U.S. Patent Office that apply to two of ... handling to ensure the consistency of test conditions ... Patent number 8,388,912 covers CoolSink® ...
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... Amerivet Solutions, LLC ( AMERIVET ), ... government from Federal to Municipal, is pleased to ... include complex metal design and fabrication manufacturing. "We ... aluminum parts for the Defense Logistics Agency (DLA) ... service government contracts," states Richard Bergen , ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Drug Patent Watch 2Drug Patent Watch 3Amerivet Solutions Expands to Manufacture Complex Metal Designs 2
... Jan. 31, 2012  Kerry Ingredients & Flavours is expanding ... include a new Cell Science laboratory. Building on the ... the new Cell Science laboratory will incorporate state-of-the-art technologies ... bio-pharma customers and technology partners. "The ...
... Jan. 31, 2012  Par Pharmaceutical Companies, Inc. (NYSE: PRX ... live webcast on Tuesday, February 28, 2012 at 9:00 AM EST ... The Company will release its financial results on February 28, 2012 ... can be made via the Company,s website at www.parpharm.com . ...
Cached Medicine Technology:Kerry to Expand Center of Excellence with New Cell Science Laboratory Serving Bio-Pharma Customers Globally 2
(Date:6/19/2013)... 19, 2013 Ultimate Medical Academy (UMA) ... 11.5-hour broadcast on WFLA News Channel 8. Since its ... than $84 million for All Children's Hospital in St. ... "30 Years of Miracles," marked the second year UMA ... employees worked the phones during the Telethon, which raised ...
(Date:6/19/2013)... 2013 The former internist for the ... MD, now serves as director of prevention and wellness ... his own personal encounter with a metabolic syndrome diagnosis ... Over Knives , that he credits with sparking the ... his medical practice. , “The average medical student gets ...
(Date:6/19/2013)... 19, 2013 Next Thursday, June ... kids entertainment media organization, and Muzzy Lane ... will be introducing the Games for Health community ... game is geared toward students in grades 4-7 ... lifestyles by rewarding positive choices. The game is ...
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... Recently, SoCal CEO Magazine staff was ... their third in a series of six workshops where people with ... helped place the mosaic tiles in their permanent location under the ... and Greg Maxwell. , This mural project began in March ... root over three years ago with the goal of promoting ...
Breaking Medicine News(10 mins):Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2
... efforts to cut back, , , SATURDAY, April 25 (HealthDay News) ... important lifestyle changes people with heart failure can make, but ... has found. , Researchers asked 116 people with heart ... Though the recommended daily intake of sodium for people with ...
... more potent treatment with fewer side effects , , SATURDAY, ... more direct delivery of cancer drugs to tumors have ... safe, biodegradable polymer, the nanoparticles are chemically engineered to ... most human tumors, and to carry a higher concentration ...
... - Plastic Surgery increased too, with breast implants and ... bank balances and stunning senior celebs are influencing factors.MANCHESTER, ... has been seen by staff at Transform, the UK,s ... Botox Grannies.More and more women over 60 are having ...
... Research , an association of technology analysts, market researchers, and science ... for expanding the pool of associates and tripling of publication schedule ... ... 2009 -- STIX Market Research , an association of technology ...
... a person,s insurance coverage affect their access to quality ... Center, insurance coverage may not only affect a patient,s ... care they receive. Research findings, presented today at the ... a national debate on healthcare reform. , "We ...
... Ill., April 24 World Veterinary Day, April 25, ... farmers. "This year,s theme, ,Veterinarians and Livestock ... partnership, highlights a discipline of veterinary medicine ... said Dr. W. Ron DeHaven, DVM, MBA, Chief Executive ...
Cached Medicine News:Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Nanoparticles May Help Attack Cancer More Directly 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 2Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 4Health News:Does a person's insurance coverage affect their access to quality cancer care? 2Health News:AVMA Celebrates World Veterinary Day 2
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
Foreign body spud angled, lightly rounded tip....
Optik K & Rs bandage lens is a high water content, therapeutic lens which is ideal for practitioners who recognize the importance of a quality bandage lens....
John weiss, wright acrylic globe....
Medicine Products: